Your institution may have access to this item. Find your institution then sign in to continue.
Title
Review article: probiotics for the treatment of irritable bowel syndrome--focus on lactic acid bacteria.
Authors
Clarke, G; Cryan, J F; Dinan, T G; Quigley, E M
Abstract
Irritable bowel syndrome (IBS) is a poorly understood, yet highly prevalent functional gastrointestinal disorder (FGID). The withdrawal, due to adverse events, of a number of pharmacological agents that were approved for the treatment of IBS has left a therapeutic vacuum for patients suffering from the disorder.